PlainRecalls
FDA Drug Low Class III Terminated

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

Reported: January 23, 2013 Initiated: April 24, 2012 #D-128-2013

Product Description

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

Reason for Recall

Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

Details

Units Affected
13,232 bottles
Distribution
Nationwide
Location
Sellersville, PA

Frequently Asked Questions

What product was recalled?
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 13,232 bottles.
Why was this product recalled?
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Which agency issued this recall?
This recall was issued by the FDA Drug on January 23, 2013. Severity: Low. Recall number: D-128-2013.